• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

5-芳基-1-芳亚氨基-1-咪唑-2(3)-硫酮:合成与体外抗癌活性评价。

5-Aryl-1-Arylideneamino-1-Imidazole-2(3)-Thiones: Synthesis and In Vitro Anticancer Evaluation.

机构信息

Zoology Department, Faculty of Science, Port Said University, Port Said 42526, Egypt.

Chemistry Department, Faculty of Science, Port Said University, Port Said 42526, Egypt.

出版信息

Molecules. 2021 Mar 18;26(6):1706. doi: 10.3390/molecules26061706.

DOI:10.3390/molecules26061706
PMID:33803877
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8003321/
Abstract

A novel series of arylidene amino imidazole-2-thiones were synthesized, identified using IR, H-NMR, and C-NMR spectral data. Cytotoxic effect of the prepared compounds was carried out utilizing three cancer cell lines; MCF-7 breast cancer, HepG2 liver cancer, and HCT-116 colon cancer cell lines. Imidazole derivative was the most potent of all against three cell lines. DNA flow cytometric analysis showed that, imidazoles and exhibit pre-G1 apoptosis and cell cycle arrest at G2/M phase. The results of the VEGFR-2 and B-Raf kinase inhibition assay revealed that compounds and displayed good inhibitory activity compared with reference drug erlotinib.

摘要

合成了一系列新型芳基亚氨基咪唑-2-硫酮,并通过红外光谱(IR)、氢核磁共振谱(H-NMR)和碳核磁共振谱(C-NMR)数据进行了鉴定。利用 MCF-7 乳腺癌、HepG2 肝癌和 HCT-116 结肠癌三种癌细胞系进行了所制备化合物的细胞毒性作用实验。咪唑衍生物 对三种细胞系的抑制活性最强。DNA 流式细胞术分析表明,咪唑 和 诱导细胞发生 G2/M 期细胞周期阻滞和 Pre-G1 期凋亡。VEGFR-2 和 B-Raf 激酶抑制实验的结果表明,与对照药物厄洛替尼相比,化合物 和 显示出良好的抑制活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8efb/8003321/043a8bfc4c05/molecules-26-01706-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8efb/8003321/b417957b0050/molecules-26-01706-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8efb/8003321/043a8bfc4c05/molecules-26-01706-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8efb/8003321/b417957b0050/molecules-26-01706-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8efb/8003321/043a8bfc4c05/molecules-26-01706-g003.jpg

相似文献

1
5-Aryl-1-Arylideneamino-1-Imidazole-2(3)-Thiones: Synthesis and In Vitro Anticancer Evaluation.5-芳基-1-芳亚氨基-1-咪唑-2(3)-硫酮:合成与体外抗癌活性评价。
Molecules. 2021 Mar 18;26(6):1706. doi: 10.3390/molecules26061706.
2
Synthesis, anticancer effect and molecular modeling of new thiazolylpyrazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosis.合成、抗癌作用及新型噻唑基吡唑并香豆素衍生物的分子模拟,该衍生物针对 VEGFR-2 激酶并诱导细胞周期停滞和细胞凋亡。
Bioorg Chem. 2019 Apr;85:253-273. doi: 10.1016/j.bioorg.2018.12.040. Epub 2019 Jan 3.
3
Design, synthesis, and in vitro antitumor activity of new 1,4-diarylimidazole-2-ones and their 2-thione analogues.新型1,4-二芳基咪唑-2-酮及其2-硫酮类似物的设计、合成与体外抗肿瘤活性
Bioorg Med Chem Lett. 2008 Feb 1;18(3):989-93. doi: 10.1016/j.bmcl.2007.12.023. Epub 2007 Dec 15.
4
EGFR/VEGFR-2 dual inhibitor and apoptotic inducer: Design, synthesis, anticancer activity and docking study of new 2-thioxoimidazolidin-4one derivatives.表皮生长因子受体/血管内皮生长因子受体-2 双重抑制剂和凋亡诱导剂:新型 2-硫代亚氨唑烷-4-酮衍生物的设计、合成、抗癌活性及对接研究。
Life Sci. 2021 Jul 15;277:119531. doi: 10.1016/j.lfs.2021.119531. Epub 2021 Apr 21.
5
Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.靶向VEGFR-2酶的新型三唑并[3,4-a]酞嗪衍生物的设计、合成、体外抗癌活性、ADMET特性及分子对接
Anticancer Agents Med Chem. 2018;18(8):1184-1196. doi: 10.2174/1871520618666180412123833.
6
cytotoxicity screening of some 3-substituted-4-oxo-imidazolidin-2-(1H)-thione derivatives as anticancer drug.作为抗癌药物的一些 3-取代-4-氧代-2-(1H)-噻唑烷-2-硫酮衍生物的细胞毒性筛选。
Future Med Chem. 2024;16(14):1379-1393. doi: 10.1080/17568919.2024.2350925. Epub 2024 May 24.
7
1,3,4-oxadiazole-2-thione Derivatives; Novel Approach for Anticancer and Tubulin Polymerization Inhibitory Activities.1,3,4-恶二唑-2-硫酮衍生物;抗癌及微管蛋白聚合抑制活性的新方法
Anticancer Agents Med Chem. 2015;16(2):269-77. doi: 10.2174/1871520615666150907093855.
8
New thiazole-2(3H)-thiones containing 4-(3,4,5-trimethoxyphenyl) moiety as anticancer agents.含有 4-(3,4,5-三甲氧基苯基)部分的新型噻唑-2(3H)-硫酮类化合物作为抗癌剂。
Eur J Med Chem. 2020 Jan 1;185:111784. doi: 10.1016/j.ejmech.2019.111784. Epub 2019 Oct 15.
9
Azole-hydrazone derivatives: Design, synthesis, in vitro biological evaluation, dual EGFR/HER2 inhibitory activity, cell cycle analysis and molecular docking study as anticancer agents.唑-酰腙衍生物:作为抗癌剂的设计、合成、体外生物学评价、双重 EGFR/HER2 抑制活性、细胞周期分析和分子对接研究。
Bioorg Chem. 2018 Feb;76:67-80. doi: 10.1016/j.bioorg.2017.10.016. Epub 2017 Nov 15.
10
Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.新型2-呋喃苯并咪唑类VEGFR-2抑制剂的设计、合成、分子对接及细胞毒性评价
Eur J Med Chem. 2017 Aug 18;136:315-329. doi: 10.1016/j.ejmech.2017.04.068. Epub 2017 Apr 26.

引用本文的文献

1
Synthesis of Thiazolidin-4-Ones Derivatives, Evaluation of Conformation in Solution, Theoretical Isomerization Reaction Paths and Discovery of Potential Biological Targets.噻唑烷-4-酮衍生物的合成、溶液构象的评估、理论异构化反应途径和潜在生物靶标的发现。
Molecules. 2024 May 23;29(11):2458. doi: 10.3390/molecules29112458.
2
Chemotherapeutic Activities of New η--Cymene Ruthenium(II) and Osmium(II) Complexes with Chelating SS and Tridentate SNS Ligands.新型η-对异丙基苯钌(II)和锇(II)与螯合SS和三齿SNS配体配合物的化疗活性
Molecules. 2024 Feb 21;29(5):944. doi: 10.3390/molecules29050944.
3
Design, Synthesis, In Vitro Biological Activity Evaluation and Stabilized Nanostructured Lipid Carrier Formulation of Newly Synthesized Schiff Bases-Based TMP Moieties.

本文引用的文献

1
Epigenetic Alterations in Renal Cell Cancer With TKIs Resistance: From Mechanisms to Clinical Applications.肾细胞癌对酪氨酸激酶抑制剂耐药的表观遗传改变:从机制到临床应用
Front Genet. 2021 Jan 12;11:562868. doi: 10.3389/fgene.2020.562868. eCollection 2020.
2
Design, synthesis, and biological evaluation of novel imidazole derivatives possessing terminal sulphonamides as potential BRAFinhibitors.新型含末端磺酰胺基咪唑衍生物的设计、合成及生物评价作为潜在的 BRAF 抑制剂。
Bioorg Chem. 2021 Jan;106:104508. doi: 10.1016/j.bioorg.2020.104508. Epub 2020 Nov 24.
3
Selective stabilization of multiple promoter G-quadruplex DNA by using 2-phenyl-1H-imidazole-based tanshinone IIA derivatives and their potential suppressing function in the metastatic breast cancer.
新合成的基于席夫碱的甲氧苄啶部分的设计、合成、体外生物活性评价及稳定化纳米结构脂质载体配方
Pharmaceuticals (Basel). 2022 May 28;15(6):679. doi: 10.3390/ph15060679.
4
Design and Synthesis of Some New Furan-Based Derivatives and Evaluation of In Vitro Cytotoxic Activity.设计和合成一些新型呋喃基衍生物,并评估其体外细胞毒性活性。
Molecules. 2022 Apr 18;27(8):2606. doi: 10.3390/molecules27082606.
5
In Silico and In Vitro Studies for Benzimidazole Anthelmintics Repurposing as VEGFR-2 Antagonists: Novel Mebendazole-Loaded Mixed Micelles with Enhanced Dissolution and Anticancer Activity.苯并咪唑驱虫药作为VEGFR-2拮抗剂的计算机模拟和体外研究:具有增强溶解性和抗癌活性的新型载有甲苯咪唑的混合胶束
ACS Omega. 2021 Dec 22;7(1):875-899. doi: 10.1021/acsomega.1c05519. eCollection 2022 Jan 11.
6
Design and Synthesis of Newly Synthesized Acrylamide Derivatives as Potential Chemotherapeutic Agents against MCF-7 Breast Cancer Cell Line Lodged on PEGylated Bilosomal Nano-Vesicles for Improving Cytotoxic Activity.新型合成丙烯酰胺衍生物的设计与合成,作为潜在的化疗药物用于对抗MCF-7乳腺癌细胞系,负载于聚乙二醇化双体纳米囊泡以提高细胞毒性活性。
Pharmaceuticals (Basel). 2021 Oct 4;14(10):1021. doi: 10.3390/ph14101021.
7
Design, Synthesis, and Antipoliferative Activities of Novel Substituted Imidazole-Thione Linked Benzotriazole Derivatives.新型取代咪唑-硫酮连接苯并三唑衍生物的设计、合成及抗增殖活性。
Molecules. 2021 Oct 2;26(19):5983. doi: 10.3390/molecules26195983.
8
Evaluation of Synthetic 2,4-Disubstituted-benzo[]quinoxaline Derivatives as Potential Anticancer Agents.评估合成的2,4-二取代苯并喹喔啉衍生物作为潜在抗癌药物的研究
Pharmaceuticals (Basel). 2021 Aug 26;14(9):853. doi: 10.3390/ph14090853.
使用基于 2-苯基-1H-咪唑的丹参酮 IIA 衍生物选择性稳定多个启动子 G-四链体 DNA 及其在转移性乳腺癌中的潜在抑制功能。
Bioorg Chem. 2021 Jan;106:104433. doi: 10.1016/j.bioorg.2020.104433. Epub 2020 Oct 31.
4
Discovery of novel isatin-based thiosemicarbazones: synthesis, antibacterial, antifungal, and antimycobacterial screening.新型异吲哚酮基硫代氨基脲的发现:合成、抗菌、抗真菌及抗分枝杆菌筛选
Res Pharm Sci. 2020 Jul 3;15(3):281-290. doi: 10.4103/1735-5362.288435. eCollection 2020 Jun.
5
Systemic review on B-Raf mutation as potential therapeutic target for the treatment of cancer.关于B-Raf突变作为癌症治疗潜在靶点的系统评价。
Eur J Med Chem. 2020 Nov 15;206:112675. doi: 10.1016/j.ejmech.2020.112675. Epub 2020 Aug 1.
6
Design, synthesis, and cytotoxicity screening of new synthesized imidazolidine-2-thiones as VEGFR-2 enzyme inhibitors.新型咪唑烷-2-硫酮类 VEGFR-2 酶抑制剂的设计、合成与细胞毒性筛选。
Arch Pharm (Weinheim). 2020 Nov;353(11):e2000121. doi: 10.1002/ardp.202000121. Epub 2020 Aug 5.
7
Design, synthesis, and cytotoxic screening of novel azole derivatives on hepatocellular carcinoma (HepG2 Cells).新型唑类衍生物的设计、合成与肝癌(HepG2 细胞)细胞毒性筛选。
Bioorg Chem. 2020 Aug;101:103995. doi: 10.1016/j.bioorg.2020.103995. Epub 2020 Jun 3.
8
Synthesis and anticancer evaluation of novel 1H-benzo[d]imidazole derivatives of dehydroabietic acid as PI3Kα inhibitors.新型去氢枞酸 1H-苯并[d]咪唑衍生物的合成及其作为 PI3Kα 抑制剂的抗癌活性评价。
Bioorg Chem. 2020 Jul;100:103845. doi: 10.1016/j.bioorg.2020.103845. Epub 2020 Apr 10.
9
1,3,5-Triazine-azole Hybrids and their Anticancer Activity.1,3,5-三嗪-唑杂化物及其抗癌活性。
Curr Top Med Chem. 2020;20(16):1481-1492. doi: 10.2174/1568026620666200310122741.
10
Not all cancers are created equal: Tissue specificity in cancer genes and pathways.并非所有癌症都是平等产生的:癌症基因和通路的组织特异性。
Curr Opin Cell Biol. 2020 Apr;63:135-143. doi: 10.1016/j.ceb.2020.01.005. Epub 2020 Feb 21.